Correspondence
Prostate cancer and hypofractionation: reflections on recent randomised phase III clinical trial results
Abstract
Four large randomised controlled trials testing modest hypofractionation for localised prostate cancer have reported efficacy and side effect outcomes within the last year (1-8).
